Webinar discussion

GenomeArc Horizon

A multi-OMICs Platform for Clinical Genomics

Unlocking Your Genomic Potential Through GenomeArc Horizon
Our Most Comprehensive multi-OMICs Clinical Genomic Platform

GenomeArc Horizon is a multi-OMICs platform for genomic diagnosis and discovery. Integrated with artificial intelligence and massive clinical genomic databases from rare diseases and pan cancer, GenomeArc Horizon classify genomic variants to enable diagnosis and therapeutic intervention.

Ultra-Fast ACMG Guided Diagnosis

A fully automated platform integrated all clinical genomic databases to aid rapid diagnosis within minutes.

ACMG Guided Diagnosis support for Rare Disease and Inherited Cancer:

Pathogenicity classification for all type of variants (SNVs/Indels and SVs)

Ultra-fast: from VCF to pathogenicity classification

  • Exome under 5 minutes
  • Whole genome under 10 minutes

Carrier Screening

Understand your family’s future
health.

Carrier Screening of over 500 globally prevalent recessive diseases.

Extended Carrier Screening covering all Mendelian disease genes.

Secondary Findings

Identify accidental findings on actionable gene known to cause diseases.

ACMG Secondary Finding Genes screening that are known to be causal for diseases.

Clinically Actionable genes by established intervention.

Horizon Intelligence

A dynamic language model that is embedded within the
platform and provides information through a prompt.

Symptoms to Gene Panel creation is one of the way Horizon Intelligence connect phenotype with genotype for diagnosis.


Dynamic Learning updates the intelligence of the platform with uploaded genome and phenotype data.


Molecular Genomics Knowledge provides gene, variant and disease information from a prompt.

Accuracy

GenomeArc Horizon has been utilized across various genetic disease cohorts, delivering higher diagnostic yields compared to traditional analytical tools. It achieved a benchmark of 90% accuracy in classifying the pathogenicity of structural variants.

Pharmacogenomics

Find the drug-gene insights from rare genetic diseases and cancer

Pharmacogenomic Insight from over thouands of drugs that are tested for numerous conditions.

Proprietary Database updates gene-drug information to implement precision medicine.

Identifies Variants association with drugs.

Liquid Biopsy

Provides predictive cancery type information from liquid biopsy varaints

Liquid Biopsy Profiling from cell free DNA gene panel or exome sequencing data, variants can predict cancer outcome.

Tumour Profiling from germline and tumor pair, somatic variant profiling is extremely easy. Identifies all tumor spicific variants upto 5% detection rate.

Multi-OMICs Integration

Proteomics

Protein Expression Map a comprehensive dataset of protein expression across human tissues, linking pathogenic genes to tissue-specific protein expression.

Custom Mass-spectrometry Protein Expression data can be uploaded into projects for cancer or rare disease projects.

Single Cell Transcriptomics

Single Cell Atlas provides a comprehensive map of single-cell transcriptome cell-type expression across human tissues.

Custom Single Cell Transcriptome data can be uploaded into projects for cancer or rare disease projects.

Single Cell Visual UI connects pathogenic gene expression to specific cell types.

Request for Demo